We are looking for children to join a research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderate to severe IBD (including associated symptoms such as rectal bleeding, kidney stones, cramps, weight loss and/or liver disease), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.
Your child may be eligible to take part in the clinical trials if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
